Cambridge Healthtech Institute

Name

Cambridge Healthtech Institute

Legal name

Cambridge Healthtech Institute

Website

https://healthtech.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Life Science Conferences and Events

NAICS

Professional, Scientific, and Technical Services (541)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

akta.pro secondary industry

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC)

Keywords

• Life science conferences
• Biopharma events
• Clinical operations summits
• Bioprocessing conferences
• Drug discovery summits

Headquarters

HQ city

Needham Heights

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Conference Registration: Revenue generated from attendee registration fees for in-person and virtual conferences across the biopharma, biotech, and life science sectors.
2. Sponsorship and Exhibition: Revenue from companies sponsoring events and purchasing exhibit space to reach the professional audience at CHI conferences.
3. Lead Generation Services: Demand generation programs including webinars, whitepapers, eBooks, and podcasts that provide qualified leads to sponsors and exhibitors.
4. Publications and Content: Revenue from Healthtech Publishing division including Bio-IT World, Clinical Informatics News, and Diagnostics World News publications, e-newsletters, and related content.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

Cambridge Healthtech Institute (CHI) operates a portfolio of over 120 annual in-person and virtual conferences serving senior researchers, executives, and decision makers in the pharmaceutical, biotechnology, and academic life science sectors, covering drug discovery, bioprocessing, clinical operations, immuno-oncology, diagnostics, biopharma portfolio strategy, and precision medicine. The portfolio also includes Healthtech Publishing (Bio-IT World, Clinical Informatics News, Diagnostics World News publications and e-newsletters), The Chain protein engineering podcast, lead generation services for sponsors, on-demand virtual content, short courses and virtual workshops, and the Barnett Educational Services training division.

Product overview

Cambridge Healthtech Institute (CHI) is a life science conference and educational services company operating a platform of over 120 annual events for pharmaceutical, biotech, and academic researchers. The portfolio includes core conference series (Bioprocessing Summit, PEGS Summit, SCOPE Summit, EP3M Summit, TRI-CON, Discovery on Target, Drug Discovery Chemistry, Immuno-Oncology Summit, PepTalk, OPT Congress, Next Generation Dx Summit), supported by Healthtech Publishing (Bio-IT World, Clinical Informatics News, Diagnostics World News) and The Chain podcast. CHI also provides lead generation services (webinars, whitepapers, eBooks, podcasts), on-demand conference access, and short courses. The company was founded in 1992 and acquired Evaluating Biopharma in 2022, expanding its clinical research portfolio.

Differentiator

Problem solved

Functional benefit

Products and services

• CHI Conferences Portfolio of over 120 annual in-person and virtual professional conferences covering drug discovery, bioprocessing, clinical operations, immuno-oncology, biopharma portfolio strategy, diagnostics, precision medicine, and related life science topics for senior researchers, executives, and decision makers in the pharmaceutical, biotech, and academic sectors.
• Healthtech Publishing Publications division including Bio-IT World, Clinical Informatics News, and Diagnostics World News, along with e-newsletters providing industry news, insights, and coverage of the life science sector.
• The Chain: Protein Engineering Podcast Podcast exploring the lives, careers, research, and discoveries of protein engineers and scientists, with episodes featuring industry leaders and young scientist keynotes, available on iTunes and other podcast platforms.
• Lead Generation Services Demand generation programs including webinars, whitepapers, eBooks, and podcasts designed to deliver qualified leads to sponsors and exhibitors targeting CHI's life science professional audience.
• On-Demand Conferences Virtual access to recorded conference content available on-demand for one year following events, allowing remote attendees to revisit sessions from anywhere.
• Short Courses and Virtual Workshops Educational short courses and virtual workshops providing professional development and training for life science professionals.
• Barnett Educational Services Educational services division providing training and professional development resources for the life science industry.
• Bioprocessing Summit Annual conference focused on bioprocessing, cell line development, upstream/downstream processing, and manufacturing for biologics.
• PEGS Summit (Protein and Antibody Engineering Summit) Essential protein and antibody engineering summit covering protein engineering, antibodies, and cell therapy, launched in 1997 by Christina Lingham.
• SCOPE Summit (Summit for Clinical Ops Executives) Clinical operations executive summit covering clinical trial optimization, data strategies, and AI applications in clinical research.
• EP3M Summit Professional conference for pharmaceutical and biotechnology portfolio leaders focusing on portfolio strategy, decision intelligence, and innovation portfolio management.
• Bio-IT World Conference and Expo Conference focused on operationalizing AI across drug discovery, development, and clinical workflows, featuring tracks on Generative AI and federated learning, with approximately 2,900 attendees at the 25th annual event.
• TRI-CON (Molecular Medicine Tri-Conference) Tri-conference event covering molecular medicine, precision medicine, and precision oncology topics.
• Discovery on Target Annual conference focused on drug discovery target identification and validation, covering emerging therapeutic targets.
• Drug Discovery Chemistry Conference covering medicinal chemistry, hit identification, and drug discovery chemistry methodologies.
• Immuno-Oncology Summit Summit focused on cancer immunotherapy research, T-cell engagers, and immuno-oncology clinical development.
• PepTalk (Protein Science and Production Week) Week-long event covering protein science, expression, purification, and analytical characterization.
• OPT Congress (Oligonucleotides and mRNA Therapeutics) Congress covering oligonucleotide and mRNA therapeutics, including delivery technologies and manufacturing.
• Strategic Alliance Management Congress Conference focused on biotech-pharma partnerships, licensing deals, and alliance management strategies.
• Next Generation Dx Summit Conference covering advanced diagnostics, biomarker testing, and coverage/reimbursement trends for diagnostics.
• ImmunoGenicity Summit Summit focused on immunogenicity assessment, bioassay development, and immunogenicity prediction for biologics.
• SCOPE X (Data Strategies and AI Innovation in Clinical Research) Executive forum for clinical research executives focusing on AI and data strategies for clinical trial optimization and AI strategy in clinical development.
• Biologics Summit Summit focused on AI/ML applications for biologic drug development, covering machine learning in biologics R&D.
• Future of Mental Healthcare Conference addressing innovations and transformations in mental healthcare treatment and delivery.
• Oncology VIP Summit Summit focused on oncology venture, innovation, and partnering for industry leaders.
• Innov8Health Event focused on digital health innovation and technology solutions in healthcare.
• Food as Medicine: Policy and Research Summit Conference focusing on policy updates and industry responses for food as medicine, addressing the intersection of nutrition, policy, and health outcomes.
• Health Executive and Research Summit (HERS) Event focused on women health executives, addressing leadership, research, and innovation in women's health.
• Ophthalmology Innovation Summit (OIS) Summit focused on ophthalmology and retina innovation, covering therapeutic development and venture investment in eye care.
• Conquering Obesity Summit Conference addressing obesity treatment, therapeutics development, and clinical research in metabolic disease.
• MedTech MVP Conference covering medical technology innovation and venture, addressing medtech development and commercialization.
• Evaluating Biopharma (EBP) Biopharma evaluation and portfolio analysis services supporting deal-making, licensing, and partnership decisions across the biopharmaceutical industry.
• ClinEco Platform and community for clinical research and clinical operations professionals, supporting collaboration across the clinical research ecosystem.

Named customers12 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• SCOPE 365coreStrategic or Co-development Partner · 26 March 2026SCOPE X: Data Strategies & AI Innovation in Clinical Research is a new executive forum hosted by Cambridge Healthtech Institute as part of the SCOPE 365 portfolio of executive-level experiences in clinical research. The two-day event focuses on AI and data for clinical trial optimization and AI strategy in clinical development.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Clarivate Events: Clarivate (formerly Thomson Reuters Life Sciences) runs proprietary events such as BioReliance End-to-End Solutions alongside its analytics and IP portfolio; it competes with CHI for life science executive audiences while offering broader data and analytics products.
• Informa: Informa is the world's largest B2B events organizer (Taylor & Francis, Informa Markets, Informa Connect) with significant life sciences portfolio including BioEurope and partnerships across pharma; it competes with CHI for sponsors and attendees but operates at vastly greater scale and geographic breadth.

Others

• Fierce Biotech: Fierce Biotech (part of Questex) publishes life sciences news and runs industry events covering biotech and pharma; it is comparable to CHI as a life sciences media and events peer, with overlapping audiences for news and executive engagement.

Direct peers

• Hanson Wade: Hanson Wade is a specialist B2B conference organizer focused on life sciences, biotech, and healthcare verticals; it is a close direct peer to CHI in niche event production, sponsor monetization, and senior-level audience targeting.
• BioCentury: BioCentury is a life sciences media and information business (publications, databases, industry events) targeting biopharma executives; it overlaps with CHI's Healthtech Publishing division and runs complementary conferences such as the BioCentury Annual Conference.
• The Conference Forum: The Conference Forum produces life sciences conferences (e.g., Clinical Trial Innovation Summit, Patients as Partners) targeting pharma executives; it directly competes with CHI in the clinical research and drug development event vertical.
• Arena International: Arena International organizes B2B conferences across pharma, biotech, and healthcare; it is comparable to CHI in event-driven GTM, sponsor monetization, and target audience of senior industry executives.
• Oxford Global: Oxford Global organizes life sciences conferences covering drug discovery, biologics, and genomics; it is comparable to CHI's PEGS, Biologics Summit, and Discovery on Target flagship brands.
• Marcus Evans Life Sciences: Marcus Evans runs premium business conferences including life sciences summits (Pharmaceutical, Biotech, Medical Device); it competes with CHI in high-end executive event production and sponsorship monetization.
• LSX (Leaders in Pharma): LSX Leaders organizes partnering and investment conferences for pharma executives and biotech investors (e.g., LSX World Congress); it directly competes with CHI's Strategic Alliance Management Congress and Oncology VIP Summit in the executive partnering space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/CHI_Healthtech
• YouTubeyoutube.com/user/CambridgeHealthtech
• Facebookfacebook.com/HealthtechConferences
• LinkedInlinkedin.com/company/cambridge-healthtech-institute

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cambridge Healthtech Institute